Elyashiv, Osnat http://orcid.org/0000-0001-8797-9538
Wong, Yien Ning Sophia http://orcid.org/0000-0003-1903-6110
Ledermann, Jonathan A. http://orcid.org/0000-0003-3799-3539
Article History
Accepted: 3 May 2021
First Online: 14 June 2021
Declarations
:
: Osnat Elyashiv and Yien Ning Sophia Wong declare no conflict of interest. Jonathan A. Ledermann is supported in part by institutional research grants from AstraZeneca and MSD/Merck; received compensation for participation on advisory boards from AstraZeneca, GlaxoSmithKline, MSD/Merck, Clovis Oncology, Eisai, Artios Pharma, and Pfizer; has received speaker’s honoraria from AstraZeneca, GlaxoSmithKline, Clovis Oncology, and Eisai; and received compensation from Regeneron for participating on an independent data monitoring committee.
: This article does not contain any studies with human or animal subjects performed by the authors.